Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

计划入组 56 人 · 首次发布于 2009 年 12 月 17 日

Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

计划入组 40 人 · 首次发布于 2008 年 7 月 25 日

Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders

计划入组 50 人 · 首次发布于 2010 年 7 月 20 日

Luteinizing hormone(Menopur)

hormone therapy

thyroid hormone

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

LAWLEY PHARMACEUTICALS PTY LTD

Australia

Vanda Pharmaceuticals

United States

FDA Rejects Camurus' Investigational Drug for Rare Hormone Disorder

FDA Issues Complete Response Letter for Camurus' Acromegaly Drug CAM2029

Avicursen Shows Promise in Phase II Trial for Duchenne Muscular Dystrophy